NO893021L - Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228. - Google Patents

Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.

Info

Publication number
NO893021L
NO893021L NO89893021A NO893021A NO893021L NO 893021 L NO893021 L NO 893021L NO 89893021 A NO89893021 A NO 89893021A NO 893021 A NO893021 A NO 893021A NO 893021 L NO893021 L NO 893021L
Authority
NO
Norway
Prior art keywords
substance
preparing
procedure
active compound
biological active
Prior art date
Application number
NO89893021A
Other languages
English (en)
Norwegian (no)
Other versions
NO893021D0 (no
Inventor
Masakuni Okuhara
Toshio Goto
Yasuhiro Hori
Takashi Fujita
Hirotsugu Ueda
Nobuharu Shigematsu
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10641100&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO893021(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO893021D0 publication Critical patent/NO893021D0/no
Publication of NO893021L publication Critical patent/NO893021L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Reinforced Plastic Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO89893021A 1988-07-26 1989-07-25 Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228. NO893021L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817743A GB8817743D0 (en) 1988-07-26 1988-07-26 Fr901228 substance & preparation thereof

Publications (2)

Publication Number Publication Date
NO893021D0 NO893021D0 (no) 1989-07-25
NO893021L true NO893021L (no) 1990-01-29

Family

ID=10641100

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893021A NO893021L (no) 1988-07-26 1989-07-25 Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.

Country Status (16)

Country Link
US (1) US4977138A (de)
EP (1) EP0352646B1 (de)
JP (1) JPH0764872B2 (de)
CN (1) CN1040054A (de)
AT (1) ATE94561T1 (de)
AU (1) AU3829089A (de)
CA (1) CA1335083C (de)
DE (1) DE68909139T2 (de)
DK (1) DK366889A (de)
ES (1) ES2058411T3 (de)
FI (1) FI893359L (de)
GB (1) GB8817743D0 (de)
HU (1) HU211514A9 (de)
IL (1) IL90949A0 (de)
NO (1) NO893021L (de)
ZA (1) ZA895121B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130414A (en) * 1989-11-30 1992-07-14 Arizona Board Of Regents, A Body Corporate Of Arizona State University Isolation and structural elucidation of the cyclic peptide hymenistatin 1
JPH06247964A (ja) * 1993-02-22 1994-09-06 Snow Brand Milk Prod Co Ltd 新規生理活性物質ｈｓ−１及びその製造方法
PT932663E (pt) * 1996-11-22 2000-12-29 Pioneer Hi Bred Int Composicoes e metodos para eliminar a toxicidade da moniliformina
ATE331730T1 (de) * 1999-01-13 2006-07-15 Astellas Pharma Inc Neue depsipeptid-verbindung
CA2393682C (en) * 1999-12-08 2012-01-31 Xcyte Therapies, Inc. Depsipeptide and congeners thereof for use as immunosuppressants
US6828302B1 (en) 1999-12-08 2004-12-07 Xcyte Therapies, Inc. Therapeutic uses of depsipeptides and congeners thereof
ATE425177T1 (de) * 2000-07-17 2009-03-15 Astellas Pharma Inc Reduziertes fk228 und seine verwendung
JP2004508049A (ja) * 2000-09-01 2004-03-18 藤沢薬品工業株式会社 Ｆｒ９０１２２８物質の製造法
DK1426054T3 (da) * 2001-08-21 2011-12-12 Astellas Pharma Inc Medicinsk anvendelse af histon-deacetylase-inhibitor og fremgangsmåde til evaluering af antitumor virkning deraf
US20040132643A1 (en) * 2002-01-09 2004-07-08 Fojo Antonio Tito Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms
US8673888B2 (en) * 2002-04-05 2014-03-18 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Depsipeptide for therapy of kidney cancer
EP1595952A4 (de) * 2003-02-19 2008-05-21 Astellas Pharma Inc Verfahren zur abschätzung der antitumorwirkung des histondeacetylase-inhibitors
DK2238982T3 (da) * 2003-06-27 2013-01-28 Astellas Pharma Inc Terapeutisk middel til blødt væv-sarcom
CA2540108A1 (en) 2003-09-25 2005-04-07 Astellas Pharma Inc. Antitumor agent_comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor
WO2005058298A2 (en) * 2003-12-10 2005-06-30 Wisconsin Alumni Research Foundation Fk228 analogs and their use as hdac-inhibitors
US20050187148A1 (en) * 2004-02-25 2005-08-25 Yoshinori Naoe Antitumor agent
US7951780B2 (en) * 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
WO2005115149A2 (en) * 2004-05-20 2005-12-08 Dow Agrosciences Llc Insectidal activity of a cyclic peptide
JP2008520682A (ja) * 2004-11-17 2008-06-19 ザ ユニヴァーシティー オヴ シカゴ ヒストンデアセチラーゼ阻害剤およびその使用方法
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
EP1965824A4 (de) * 2005-11-18 2011-10-19 Gloucester Pharmaceuticals Inc Metaboliten-derivate des hdac-inhibitors fk228
CA2649877A1 (en) * 2006-04-24 2007-12-21 Gloucester Pharmaceuticals Gemcitabine combination therapy
WO2007146730A2 (en) * 2006-06-08 2007-12-21 Gloucester Pharmaceuticals Deacetylase inhibitor therapy
JP2010514801A (ja) * 2006-12-29 2010-05-06 グラスター ファーマシューティカルズ， インコーポレイテッド ロミデプシンの精製
CA2674313A1 (en) * 2006-12-29 2008-07-10 Gloucester Pharmaceuticals, Inc. Romidepsin-based treatments for cancer
WO2008098199A2 (en) * 2007-02-08 2008-08-14 Uwm Research Foundation, Inc. Sequences for fk228 biosyntnesis and methods of synthesizing fk228 and fk228 analogs
US20110060021A1 (en) * 2009-08-19 2011-03-10 Yiqiang Cheng Histone deacetylase inhibitors and uses thereof
AR080234A1 (es) 2010-02-25 2012-03-21 Marrone Bio Innovations Inc Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
MX342913B (es) 2010-07-12 2016-10-19 Celgene Corp * Formas solidas de romidepsina y sus usos.
US8859502B2 (en) 2010-09-13 2014-10-14 Celgene Corporation Therapy for MLL-rearranged leukemia
WO2013032693A2 (en) * 2011-08-27 2013-03-07 Marrone Bio Innovations, Inc. Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom-formulations and uses
CN104114182A (zh) 2011-09-23 2014-10-22 细胞基因公司 罗米地辛和5-阿扎胞苷在治疗淋巴瘤中的应用
CN104039330A (zh) 2011-09-26 2014-09-10 细胞基因公司 化疗耐药性的癌症的联合治疗
JP6214397B2 (ja) 2011-09-30 2017-10-18 国立大学法人東北大学 新規ホスファチジルイノシトール３キナーゼ阻害剤及び医薬組成物
WO2013085902A1 (en) 2011-12-05 2013-06-13 The University Of Texas M.D. Combination therapy methods for treating an inflammatory breast cancer
MX2014008390A (es) 2012-01-12 2014-09-22 Celgene Corp Formulaciones de romidepsina y sus usos.
AU2013202506B2 (en) 2012-09-07 2015-06-18 Celgene Corporation Resistance biomarkers for hdac inhibitors
AU2013202507B9 (en) 2012-11-14 2015-08-13 Celgene Corporation Inhibition of drug resistant cancer cells
CN103877010B (zh) * 2012-12-21 2018-06-01 正大天晴药业集团股份有限公司 一种罗米地辛溶液的制备方法
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
ES2699257T3 (es) 2013-02-28 2019-02-08 Dermira Inc Sales de glicopirrolato
CN103173390B (zh) * 2013-03-16 2014-09-10 浙江海正药业股份有限公司 一种紫色杆菌菌株及其应用
CN104072589B (zh) * 2013-03-29 2017-09-22 浙江海正药业股份有限公司 抗肿瘤三硫化合物及其制备方法与应用
CN104447950A (zh) * 2013-09-18 2015-03-25 上海医药工业研究院 一种罗米地辛的分离纯化方法
CN104450837B (zh) * 2013-09-18 2019-01-01 上海医药工业研究院 一种用于生产罗米地辛的方法及发酵培养基
NZ630311A (en) 2013-12-27 2016-03-31 Celgene Corp Romidepsin formulations and uses thereof
US10294276B2 (en) * 2014-03-04 2019-05-21 Concord Biotech Limited Process for isolation of romidepsin from fermentation broth and preparation of crystals of romidepsin
CN104894195B (zh) * 2014-03-07 2018-11-13 上海医药工业研究院 一种提高fk228产量的发酵培养基
CN104262456B (zh) * 2014-09-11 2018-01-09 浙江海正药业股份有限公司 一种罗米地辛的新晶型及其制备方法和用途
EP3313420B1 (de) 2015-06-25 2024-03-13 The Children's Medical Center Corporation Verfahren und zusammensetzungen in bezug auf hämatopoetische stammzellenexpansion, -anreicherung und -pflege
WO2017068596A1 (en) * 2015-10-20 2017-04-27 Msn Laboratories Private Limited An improved process for the preparation of (1s, 4s, 7z, 10s, 16e, 21r)- 7-ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5, 8, 20, 23- tetraazabicyclo[8.7.6]tricos-16-ene-3, 6, 9, 19, 22-pentone
WO2017161001A1 (en) 2016-03-15 2017-09-21 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
EP3893647A1 (de) 2018-12-14 2021-10-20 Pioneer Hi-Bred International, Inc. Biologika und deren verwendung in pflanzen
EP3902908A4 (de) * 2018-12-24 2024-01-03 Pro Farm Group, Inc. Verfahren zur erhöhung der romidepsin-produktion aus fermentationsbrühe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986006065A1 (en) * 1985-04-18 1986-10-23 Pfizer Inc. Transformation product of thiosporamicin
DE3782199T2 (de) * 1986-07-08 1993-02-25 Takeda Chemical Industries Ltd Biologisch aktive peptide tan-866.
US4777160A (en) * 1986-09-18 1988-10-11 Bristol-Myers BU-2867T peptide antibiotics

Also Published As

Publication number Publication date
ES2058411T3 (es) 1994-11-01
EP0352646A2 (de) 1990-01-31
CN1040054A (zh) 1990-02-28
DE68909139T2 (de) 1994-02-10
FI893359A7 (fi) 1990-01-27
US4977138A (en) 1990-12-11
AU3829089A (en) 1990-02-01
DE68909139D1 (de) 1993-10-21
GB8817743D0 (en) 1988-09-01
DK366889A (da) 1990-01-27
JPH0764872B2 (ja) 1995-07-12
ZA895121B (en) 1990-08-29
IL90949A0 (en) 1990-02-09
EP0352646A3 (en) 1990-10-31
FI893359L (fi) 1990-01-27
EP0352646B1 (de) 1993-09-15
DK366889D0 (da) 1989-07-25
HU211514A9 (en) 1995-11-28
ATE94561T1 (de) 1993-10-15
NO893021D0 (no) 1989-07-25
FI893359A0 (fi) 1989-07-11
CA1335083C (en) 1995-04-04
JPH0285296A (ja) 1990-03-26

Similar Documents

Publication Publication Date Title
ES466791A1 (es) Procedimiento para la produccion de esterastina.
JPS5492909A (en) New aminosaccharide and its preparation
HU913396D0 (en) Process for the production of azasteroide compounds and medical preparations containing them as active agents
DK206290D0 (da) Acrylsyrederivater
JPS56128774A (en) New physiologically active substance ebelactone and its preparation
ATE151643T1 (de) Lanolinderivate als penetrationsfördernde substanzen
JPS6438049A (en) Antimicrobial agent for human or animal
IE37331B1 (en) Process for the production of a saccharase inhibitor
GB1523835A (en) Process for maximising the growth and nicotine degrading activity of microorganismus
JPS55120790A (en) Fr-900129 substance, its ester, and their preparation
MY110092A (en) Butyric acid derivatives
KR890014457A (ko) 신규 아족시 화합물 및 그의 제조방법
JPS5437889A (en) Preparation of polysaccharide
JPS6040837B2 (ja) 抗生物質チオストレプトンの製造法
GB1499710A (en) Fluidized bed waste incineration process
DE3675424D1 (de) Valiolaminderivate und ihre herstellung.
JPS56125397A (en) Oligosaccharide derivative, its preparation and preventing agent against decayed tooth containing the same as active constituent
ES471709A1 (es) Un procedimiento microbiologico para la preparacion de un nuevo complejo antibiotico
JPS5692786A (en) Cultivation of microorganism
JPS6429378A (en) Physiologically active substance and production thereof
KR880002536A (ko) 옥시란 슈도올리고삭카라이드, 이의 제조방법 및 이의 용도 및 약제학적 제제
JPS5459393A (en) Optical resolution of n-chloroacetyl-m-hydroxy-dl-phenyl- glycine
JPS5783281A (en) Novel fungus
JPS5426395A (en) Preparation of lactic acid dehydrogenase
JPS5783282A (en) Novel fungus